Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

Sinovac Starts Influenza A (H1N1) Vaccine Production

publication date: Jun 8, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech (北京科兴生物制品有限公司) has begun producing an influenza A (H1N1) pandemic vaccine. The company today received virus seed from US Centers for Disease Control. The company is aiming at delivering a vaccine as soon as October. To increase its production capacity in this emergent situation, Sinovac is collaborating with other China vaccine companies to produce supplies Panflu, its pandemic vaccine, with H1N1 virus seed. More details...

Stock Symbol: (NYSE Amex: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners